# A Study of ALPN-303 in Adult Healthy Volunteers

> **NCT05034484** · PHASE1 · COMPLETED · sponsor: **Alpine Immune Sciences, Inc.** · enrollment: 72 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ALPN-303
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05034484
- **Lead sponsor:** Alpine Immune Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-15
- **Primary completion:** 2023-02-27
- **Final completion:** 2023-02-27
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034484, "A Study of ALPN-303 in Adult Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05034484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*